Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Other Non-Current Assets (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Other Non-Current Assets for 2 consecutive years, with $402000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Other Non-Current Assets fell 15.37% to $402000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $402000.0, a 15.37% decrease, with the full-year FY2024 number at $378000.0, changed N/A from a year prior.
  • Other Non-Current Assets was $402000.0 for Q2 2025 at Mereo BioPharma, up from $380000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $475000.0 in Q2 2024 to a low of $378000.0 in Q4 2024.